Stem cell injections have been demonstrated to speed up the healing of skin sores in those suffering from diabetes, according a recent report on Finanzen.net.
A research project, led by the NYU School of Medicine, tested the effect of injecting stem cells on a signaling pathway called Nrf2 / Keap1, which is essential to cell repair however is interrupted in diabetic patients. The results of the trials demonstrated a 50% increase in the rapidity of healing of skin sores in a group of mice.
Skin sores are a common and problematic complication of Diabetes, triggered by changes in biochemistry resulting from the inability of the body to break down sugar. Not only are such skin sores painful and prone to infection, they are also less likely to heal in diabetic patients compared to skin sores in non-diabetic patients. Often, the best available treatment is simply to keep the skin sores moist and covered, however this new research generates hope for diabetics, of which there are over 30 million in the United States alone.
The stem cells used in the research, harvested from bone marrow, are Mesenchymal Stem Cells (MSC) which have multiple uses in regenerative medicine and have the potential to effectively act as “spare parts” when various boy tissues are damaged.
Grace Century President and Director of Research Scott Wolf commented “These cells (MSC) were taken from bone marrow in this particular research project, however they are the same ones found in dental pulp and further strengthens the mission of our portfolio partner Provia Lab’s Store-a-tooth for parents to store their children’s baby teeth. “Younger is better from your younger healthier self” is the company’s mantra.
Read the full story on Finanzen.net here.
Visit the website of our portfolio partner product Store-A-Tooth here.
